参考文献/References:
[1] LI Nan, MA Ying, YANG Cheng. Interaction of anticancer drug mitoxantrone with DNA analyzed by electrochemical and spectroscopic methods [J]. Biophysical Chemistry, 2005(3):199-205.doi:10.1016/j.bpc.2005.04.009.
[2] MAHESWARI P U, RAJENDIRAN V, STOECKLI-EVANS H. Interaction of rac-[Ru(5, 6-dmp)3]2+ with DNA:Enantiospecific DNA binding and ligand-promoted exciton coupling [J]. Inorganic Chemistry, 2006(1):37-50.doi:10.1021/ic060101j.
[3] WANG Bo-chu, TAN J un, ZHU Lian-cai. Selective binding of small molecules to DNA:Application and perspectives [J]. Colloids and Surfaces B:Biointerfaces, 2010(1):1-4.
[4] BRA(N)A M F, CACHO M, GRADILLAS A. Intercalators as anticancer drugs [J]. Current Pharmaceutical Design, 2001, (17):1745-1780.
[5] BRA(N)A M F, RAMOS A. Naphthalimides as anticancer agents:Synthesis and biological activity [J]. Current Medicinal Chemistry Anti-Cancer Agents, 2001(3):237-255.
[6] 朱虹, 丁健. 萘酰亚胺类化合物作为抗肿瘤药物的研发现状 [J]. 中国新药杂志, 2007, (10):742-747.doi:10.3321/j.issn:1003-3734.2007.10.003.
[7] INGRASSIA L, LEFRANC F, KISS R. Naphthalimides and azonafides as promising anti-cancer agents [J]. Current Medicinal Chemistry, 2009, (10):1192-1213.doi:10.2174/092986709787846659.
[8] L(U) Min, XU Hui. Overview of naphthalimide analogs as anticancer agents [J]. Current Medicinal Chemistry, 2009, (36):4797-4813.doi:10.2174/092986709789909576.
[9] NORTON J T, WITSCHI M A, HUANG Sui. Synthesis and anticancer activitives of 6-amino amonafide derivatives [J]. Anti-Cancer Drug Design, 2008(1):23-36.doi:10.1097/CAD.0b013e3282f00e17.
[10] ANTONINI I, VOLPINI R, BEN D D. Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs [J]. Bioorganic and Medicinal Chemistry Letters, 2008, (18):8440-8446.
[11] WU Ai-bin, XU Yu-fang, QIAN Xu-hong. Novel naphthalimide derivatives as potential apoptosis-inducing agents:Design, synthesis and biological evaluation [J]. European Journal of Medicinal Chemistry, 2009, (11):4674-4680.doi:10.1016/j.ejmech.2009.07.011.
[12] IHMELS H, OTTO D. Intercalation of organic dye molecules into double-stranded DNA:General principles and recent developments [J]. Topics in Current Chemistry, 2005.161-204.
[13] LONG E C, BARTON J K. On demonstrating DNA intercalation [J]. Accounts of Chemical Research, 1990(9):271-273.
[14] PALCHAUDHURI R, HERGENROTHER P J. DNA as a target for anticancer compounds:Methods to determine the mode of binding and the mechanism of action [J]. Current Opinion in Biotechnology, 2007(6):497-503.doi:10.1016/j.copbio.2007.09.006.
[15] WHEATE N J, BRODIE C R, ALDRICH-WRIGHT J R. DNA intercalators in cancer therapy:Organic and inorganic drugs and their spectroscopic tools of analysis [J]. Mini Reviews in Medicinal Chemistry, 2007(6):627-648.
[16] NISHIMURA T, OKOBIRA T, KELLY A M. DNA binding of tilorone:1 H NMR and calorimetric studies of the intercalation [J]. Biochemistry, 2007, (27):8156-8163.doi:10.1021/bi602402m.
[17] LI Feng, CUI Jing-nan, QIAN Xu-hong. Molecular design, chemical synthesis, and biological evaluation of ’4-1’ pentacyclic aryl/heteroaryl-imidazonaphthalimides [J]. Bioorganic and Medicinal Chemistry Letters, 2007, (15):5114-5121.
[18] SCATCHARD G, ANN N Y. The Attractions of proteins for small molecules and ions [J]. Academic Science, 1949(4):660-672.
[19] GUPTA M, ALI R. Fluorescence studies on the interacti6n of furocoumarins with DNA in the dark [J]. Journal of Biochemisitry, 1984(5):1253-1257.
[20] 杨源源, 张志超, 盛辉. 一种苊并杂环有机小分子嵌入DNA的几何学模式研究 [J]. 高等学校化学学报, 2007(3):453-457.doi:10.3321/j.issn:0251-0790.2007.03.013.
[21] 刘振佳, 司伊康, 陈晓光. 圆二色谱测定技术在小分子化合物与DNA相互作用研究中的应用 [J]. 药学学报, 2010, (12):1478-1484.